Subjects:
For Your Benefit
Topics:
aids, pediatric, anti-retroviral agents, diphtheria vaccine, hiv, hiv-1 infection, pertussis, tdap vaccine, tetanus toxoid, thoracodorsal artery perforator flap, vaccines

Policy Statement: Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine. Pediatrics. 2006;117(3):965–978. Reaffirmed June 2009

Policy Statement: Inappropriate Use of School “Readiness” Tests. Pediatrics. 1995;95(3):437–438. Reaffirmed March 2010

Policy Statement: Education of Children with Human Immunodeficiency Virus. Pediatrics. 2000;105(6):1358–1360. Reaffirmed April 2010

Policy Statement: Increasing Antiretroviral Drug Access for Children with HIV Infection. Pediatrics. 2007;119(4):838–845. Reaffirmed April 2010

Technical Report: Diagnosis of HIV-1 Infection in Children Younger Than 18 months in the United States. Pediatrics. 2007;120(6):e1547–e1562. Reaffirmed April 2010

Competing Interests

This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.

Copyright © 2010 by the American Academy of Pediatrics
2010